Clinical trial · Interventional
Efficacy of Aleo Vera Use in Prevention and Treatment of Chemotherapy-Induced Oral Mucositis in a Group of Egyptian Children with Acute Leukemia
NCT06757270CI-TRIAL-00084323completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
evaluatation the efficacy of Aleovera in prevention and treatment of chemotherapy-induced oral mucositis in children suffering from acute leukemia in terms of appearance and severity
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oral Mucositis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Second arm: Using aleovera for Prevention and Treatment of Chemotherapy-Induced Oral Mucositis | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Alovera experminted arm
- interventionNames
- Other: Second arm: Using aleovera for Prevention and Treatment of Chemotherapy-Induced Oral Mucositis
- type
- NO_INTERVENTION
- label
- second group
Primary outcomes (1)
- measure
- Prevention of oral mucositis
- timeFrame
- 2 months
- description
- Assessment the efficacy of aleo vera gel on prevention of chemotherapy-induced oral mucositis through application the gel 3 times daily then patients were assessed daily in terms of appearance and severity of oral mucositis according WHO grading system. The World Health Organization (WHO) mucositis scale is used to grade the severity of oral mucositis. Grade 0: No mucositis Grade 1: Soreness/erythema only. Grade 2: Erythema, and ulcers. Able to tolerate solids. Grade 3: Unable to tolerate solids but able to tolerate liquids. Grade 4: Unable to tolerate solids or liquids. Oral alimentation is not possible.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 3 Years
- Maximum age
- 13 Years
Show eligibility criteria text
Inclusion criteria 1. Patients suffering from Acute leukemia( Acute Lymphocytic Leukemia ). 2. Patients scheduled for chemotherapy treatment. 3. Patients who range from 3 to 13 years old. 4. Patients with no history of any chemotherapy or radiotherapy. 5 -Both sexes Exclusion Criteria 1-Patients scheduled for radiotherapy treatment . 2-Existence of any signs or symptoms of oral mucositis. 3-Unwilling to participation in the study 4- Patients with any other systemic diseases or other neoplasms.
References
Publications (0)
Data not yet available
No reference posted for this study.